Global Roxatidine Market Insights, Forecast to 2025
- Report Details
Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug. The global Roxatidine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during
- Table Of ContentMore...
Table of Contents 1 Study Coverage 1.1 Roxatidine Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Roxatidine Market Size Growth Rate by Product 1.4.2 Oral 1.4.3 Injectable 1.5 Market by End User 1.5.1 Global Roxatidine Market Size Growth Rate by End User 1.5.2 Acidity 1.5.3
- Inquiry Before Buying
- Request Sample